Further studies should be conducted to fully elucidate the precise molecular mechanisms underlying the interaction between VD3, PTX3, and VEGFA in OHSS, thus paving the way for the development of tailored therapeutic strategies. This evidence concerns the gene PTX3 and ovarian hyperstimulation syndrome.